33 -

33 - Rocha-Lima CM, Herndon JE, II, Lee ME et al. Phase II trial of irinotecan/gemcitabine as second-line therapy for relapsed and refractory small-cell lung cancer: Cancer and Leukemia Group B Study 39902. Ann Oncol 2007; 18(2):331-337.